These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3098462)

  • 41. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation.
    Cappa M; Loche S; Salvatori R; Faedda A; Borrelli P; Cella SG; Pintor C; Müller EE
    J Endocrinol Invest; 1991 Jan; 14(1):41-5. PubMed ID: 2045624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Villamil F; Astorga R; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):399-403. PubMed ID: 8319372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The anabolic steroid oxandrolone increases muscle mass in prepubertal boys with constitutional delay of growth.
    Papadimitriou A; Preece MA; Rolland-Cachera MF; Stanhope R
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):725-7. PubMed ID: 11453521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone.
    Papadimitriou A; Wacharasindhu S; Pearl K; Preece MA; Stanhope R
    Arch Dis Child; 1991 Jul; 66(7):841-3. PubMed ID: 1863096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism.
    Borges MH; DiNinno FB; Lengyel AM
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):713-8. PubMed ID: 9274702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency.
    Donaubauer J; Kiess W; Kratzsch J; Nowak T; Steinkamp H; Willgerodt H; Keller E
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):456-63. PubMed ID: 12641629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment.
    Giustina A; Girelli A; Bossoni S; Legati F; Schettino M; Wehrenberg WB
    Metabolism; 1992 May; 41(5):548-51. PubMed ID: 1375312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction.
    Aimaretti G; Bellone S; Bellone J; Chiabotto P; Baffoni C; Corneli G; Origlia C; de Sanctis C; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):287-93. PubMed ID: 10718826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic limitations of spontaneous growth hormone measurements in normally growing prepubertal children.
    Lanes R
    Am J Dis Child; 1989 Nov; 143(11):1284-6. PubMed ID: 2510497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
    Guzzaloni G; Grugni G; Morabito F
    Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for involvement of endogenous somatostatin in the galanin-induced growth hormone secretion in children.
    Loche S; Vista N; Ghigo E; Vannelli S; Arvat E; Benso L; Corda R; Cella SG; Müller EE; Pintor C
    Pediatr Res; 1990 Apr; 27(4 Pt 1):405-7. PubMed ID: 1692988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children.
    Kirk JM; Ross RJ; Trainer PJ; Froud AL; Davies SC; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1991 May; 34(5):407-11. PubMed ID: 2060150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth.
    Brain C; Hindmarsh PC; Pringle PJ; Brook CG
    Acta Paediatr Scand Suppl; 1989; 349():109-13; discussion 123-4. PubMed ID: 2546369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
    Eakman GD; Dallas JS; Ponder SW; Keenan BS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of steroid therapy and recombinant human erythropoietin on the growth of children with renal disease.
    Rees L; Rigden SP; Chantler C
    Pediatr Nephrol; 1991 Jul; 5(4):556-8. PubMed ID: 1911137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of chronic treatment with biosynthetic growth hormone (GH) on the GH response to double GH-releasing hormone administration in children with short stature.
    Scacchi M; Danesi L; Pincelli AI; Dubini A; Cavagnini F
    J Endocrinol Invest; 1997 Feb; 20(2):72-6. PubMed ID: 9125486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.